Intangible Assets

Oak Street Health’s brand and clinical model are not shown in the provided filings or metrics to create durable pricing power versus larger payer-owned or integrated care peers, so any advantage appears limited and replaceable.

No evidence in the supplied data indicates proprietary intellectual property, exclusive licenses, or regulatory barriers that would materially prevent peers from copying the care-delivery model.

The available metrics show ROIC of 10.4% and ROCE of 12.8%, which suggest some value creation but do not by themselves demonstrate an intangible moat that sustains margins versus peers over 5–10 years.

Compared with scaled healthcare services peers, the absence of disclosed brand premium or protected assets implies weaker durability and lower customer dependence on Oak’s offering.

Switching Costs

The provided information does not show contractual lock-in, workflow integration, or data migration friction that would make patients, payers, or providers materially costly to switch away from Oak’s platform.

Primary care relationships can create some continuity benefits, but those are generally weaker than the embedded switching costs seen at software-like healthcare platforms or vertically integrated peers.

The low asset turnover of 0.075x suggests a capital-intensive operating model, but capital intensity is not the same as customer switching cost and does not itself protect retention.

Relative to peers with payer integration or proprietary care-management systems, Oak’s switching costs appear modest and insufficient to support strong long-term pricing power.

Network Effects

The supplied data does not indicate a two-sided marketplace, referral flywheel, or user-generated network that would compound value as membership grows.

Primary care scale can improve local awareness and referral density, but that is not a true network effect and is typically easier for peers to replicate.

No evidence is provided that patients, providers, or payers become more dependent on Oak as adoption rises, so peer differentiation from network effects appears minimal.

Compared with platforms where each additional participant materially increases utility, Oak’s model does not show structural network advantages.

Cost Advantage

ROIC of 10.4% and ROCE of 12.8% indicate the business can earn returns above a basic capital hurdle, but the metrics do not prove a persistent unit-cost edge versus peers.

The very low asset turnover of 0.075x suggests heavy asset intensity, which usually limits the ability to translate scale into a durable cost advantage.

If Oak’s care model reduces downstream utilization or improves care coordination, that can support relative economics, but the provided data does not quantify a peer-leading cost structure.

Compared with larger integrated or payer-affiliated competitors, Oak does not show enough evidence of structurally lower costs to rate this as a strong moat.

Efficient Scale

The available information does not show that Oak operates in a market with natural local monopoly economics or that its footprint is large enough to deter entry by peers.

Primary care and value-based care markets typically support multiple competitors, which limits the ability of any one operator to capture efficient-scale protection.

No evidence is provided that Oak’s scale creates industry dependency or that incremental entrants face prohibitive fixed-cost duplication relative to the market size.

Compared with dominant infrastructure-like healthcare platforms, Oak’s scale appears insufficient to create a durable efficient-scale moat.

Overall Score

Oak’s moat appears weak versus peers because the provided evidence shows some return generation but no clear structural protection from intangible assets, switching costs, network effects, or efficient scale; the only partial support is a modest cost position, which is not enough to sustain superior pricing power or retention over 5–10 years.